Skip to main content
Equibles
AVR logo

AVR · Anteris Technologies Global Corp.

Track AVR — free

Use AVR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.09 +0.09 (+1.42%)
Russell 2000 member Rebalance outlook locked
Market Cap
$584.75M
Shares
97.46M
Volume · Oct 28 234.87K Avg daily vol (3M) 1.03M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.00 Open$5.78 Day$5.77–6.08 52W close$3.38–10.57 Avg vol 30d1.3M Short int7.9M · 8.1% float · 5.0d Short vol65% DataDec 2024–Oct 2026 Filing10-Q · Aug 11

Latest filings

8-K Entered into a material agreement · filed Sep 23, 2026

Anteris Technologies Global Corp.’s wholly owned subsidiary, Anteris Aus Operations Pty Ltd, amended its Supply & Quality Agreement with Harvey Industries Group Pty Ltd to extend the term until the earlier of December 31, 2026 and execution of a replacement agreement.

Read the 8-K
10-Q filed Aug 11, 2026
Read the 10-Q
All filings

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.24M
Trailing 12 months
Net income (TTM)
−$103.50M
Trailing 12 months
Revenue growth YoY
+63.3%
Year over year
Operating margin
-4,738.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-15.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$249.45M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+169.9%
Year over year · more shares
Price change (1Y)
+14.7%
Trailing year
Short interest
8.1%
Latest settlement · 5.0 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
· $769,000 −$21.86M '24 Q3 · $536,000 −$19.38M '24 Q4* ▼27.4% $556,000 −$21.86M '25 Q1 ▼2.2% $618,000 −$20.83M '25 Q2 ▼44.2% $429,000 −$22.24M '25 Q3 ▼42.2% $310,000 −$29.20M '25 Q4* ▼11.2% $494,000 −$23.02M '26 Q1 LATEST ▲63.3% $1.01M −$29.09M '26 Q2

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 17.5 · elevated Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −19%
below
Price vs 50-day avg −23%
below
RSI (14) 32
neutral
MACD trend Negative
52-week position 36%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −21%
trailing
6-month return −6%
trailing
YTD return +20%
this year
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow Accumulating
16 of 137 funds reported for Sep 30 · net +17.8K sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.14% of float · ▲ +18.9% MoM · 5.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
137 holders — near 1-yr high, broad support
Squeeze score 57
elevated · 0–100
Fundamentals
Fair
Revenue growth −29%
Y/Y
EPS growth +31%
Y/Y
Free cash flow $-79.8M
Balance sheet $6.7M
net cash
Quant / Vol
risk profile
Very High
Volatility 63%
annualized · 1-yr
Max drawdown −45%
past year
ATR 5.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−19% Bearish
Price vs 50-day avg
−23% Bearish
RSI (14)
32 Neutral
MACD trend
Negative Bearish
52-week position
36% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow Accumulating
16 of 137 funds reported for Sep 30 · net +17.8K sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.14% of float · ▲ +18.9% MoM · 5.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
137 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $6 · 36% Range high $11
vs 200-day avg -19% vs 50-day avg -23%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
net operating cash outflows $20.8M three months ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AVR
Anteris Technologies Global Corp.
this stock
$584.75M +20.2% -29.2% — 8.1%
ABT
Abbott Laboratories
 $179.99B -17.7% +5.7% 33.4 1.0%
MDT
Medtronic plc
 $120.18B -2.2% +8.4% 23.1 10.9%
SYK
Stryker Corp
 $115.17B -14.2% +11.2% 31.1 1.5%
BSX
Boston Scientific Corp
 $65.30B -52.7% +12.5% 18.2 2.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
137
% held
67.0%
Reported
16 of 137
Top holder
L1 Capital Pty Ltd
Held Float
View
Held by Funds
Fund positions
111
View
Short & Settlement
Short Interest Rising
Shares short
7.9M
Days to cover
5.0d
Change
+1.3M sh
View
Short Volume
Short vol %
65%
As of
Oct 27, 2026
Short Total
View
Fails to Deliver
FTD shares
1.9K
Value
$14.7K
As of
Sep 29, 2026
View
Off-Exchange
Off-exchange %
47.4%
Week of
Sep 21, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.9M
Net income (FY)
$-94.1M
EPS diluted
$-2.55
View
Filings
SEC Filings
Latest
PRE 14A
Filed
Oct 28, 2026
This year
21

Anteris Technologies Global Corp. will hold its 2026 Annual Meeting on December 2, 2026. Stockholders will vote on twenty-three (23) proposals covering Class II director elections, KPMG ratification, and equity grants for executives and directors.

View
Exempt Offerings
Offering
$11.5M
Filed
Nov 7, 2025
View

Performance

5D 20D 120D MTD YTD
AVR -4.6% -21.0% -6.1% -22.8% +20.2%
SPY +0.1% +0.7% +4.9% +0.9% +12.9%
vs SPY -4.7% -21.7% -11.0% -23.7% +7.4%
Key facts CIK 2011514 CUSIP 03675P102 13F (30d) 13 filings 13 filers Visit website Investor relations